Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac transplant vasculopathy.

J M Aranda1, J Hill

  • 1Heart Transplant Program, University of Florida at Shands, Gainesville, FL 32610-0277, USA. arandjm@medicine.ufl.edu

Chest
|December 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for proton decay via p-->e+pi0 and p-->micro+pi0 in a large water Cherenkov detector.

Physical review letters·2009
Same author

A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer.

The British journal of surgery·2009
Same author

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.

Clinical genetics·2009
Same author

Robotic laser tissue welding of sclera using chitosan films.

Lasers in surgery and medicine·2009
Same author

Stenting and colorectal cancer.

The British journal of surgery·2008
Same author

Reduced quality of bovine embryos cultured in media conditioned by exposure to an inflamed endometrium.

Australian veterinary journal·2008
Same journal

How I Do It: De-escalation of Prostacyclin-Based Therapy in Patients Treated With Sotatercept.

Chest·2026
Same journal

Eisenmenger Syndrome: The Pulmonology Perspective.

Chest·2026
Same journal

Phenotyping of pulmonary arterial hypertension associated with congenital heart disease using latent class analysis: insights from a national prospective registry.

Chest·2026
Same journal

Septic Shock and GLP-1 Analogue Association in Real World - A Propensity Score Matched Analysis.

Chest·2026
Same journal

PREVALENCE AND RISK FACTORS OF PRESERVED RATIO IMPAIRED SPIROMETRY (PRISm) IN PEOPLE WITH HIV AND MATCHED POPULATION CONTROLS.

Chest·2026
Same journal

How I Do It: Counseling Patients About Outdoor Exercise During Air Pollution Events.

Chest·2026
See all related articles

Coronary allograft vasculopathy (CAV) is an aggressive form of coronary artery disease after heart transplants. Diagnosis is challenging, and current treatments offer limited effectiveness, necessitating further research for better strategies.

Area of Science:

  • Cardiology
  • Transplantation Immunology

Background:

  • Coronary allograft vasculopathy (CAV) is the primary cause of long-term graft failure after heart transplantation.
  • Understanding CAV is crucial for improving patient survival rates post-transplant.

Purpose of the Study:

  • To review the concept of CAV as a distinct disease entity for non-transplant physicians.
  • To provide an overview of CAV's pathology, pathophysiology, diagnosis, and treatment.

Main Methods:

  • Literature review using MEDLINE database (1985-1999).
  • Data categorized into pathology, pathophysiology, presentation, diagnosis, and treatment.

Main Results:

  • CAV is an aggressive coronary artery disease driven by immunologic and non-immunologic factors, leading to intimal hyperplasia and obstruction.

Related Experiment Videos

  • Diagnosis is difficult due to denervated hearts and unreliable noninvasive methods; coronary angiography is standard surveillance.
  • Treatment involves risk factor modification and pharmacologic agents; revascularization offers limited palliative benefit.

    • Conclusions:

    • CAV presents a significant challenge in post-heart transplant care.
    • Further research is essential to develop effective preventive and therapeutic strategies for CAV.